Flatiron Health, a healthtech company transforming clinical research through technology that integrates research into everyday care, today announced a collaboration with NRG Oncology (NRG), a clinical research consortium in the National Cancer Institute (NCI)’s National Clinical Trials Network (NCTN) comprised of over 1,300 worldwide research sites, to deploy Flatiron Clinical Pipe™ in a multicenter NRG clinical trial. Flatiron Clinical Pipe™, a cutting-edge electronic health record (EHR) to electronic data capture (EDC) connector, improves efficiency and reduces time and effort of clinical study data entry.

The study published in RSOS reviews the impact of the seasonal time change on human health, considering two types of effects: those associated with the change itself, and those associated with the period during which daylight-saving time is in effect

According to a new review published this week in Archives of Geriatrics and Gerontology Plus, most studies show that more than 15% of those who care for loved ones with cancer suffer from post-traumatic stress disorder (PTSD).

Not only does our body change with age, but so does our immune system. A recent study led by the Centre for Individualised Infection Medicine (CiiM) shows exactly how immune cells age and how infections and vaccinations can influence this process. The CiiM is a joint initiative of the Helmholtz Centre for Infection Research (HZI) and Hannover Medical School (MHH). Using a big data approach, the researchers have developed a computer model called the “Single-Cell Immune Aging Clock”, which can be used to determine aging processes within individual immune cells. The scientists are making the innovative aging clock freely available for further research. They hope that it will serve as a useful tool to better understand the aging processes of the immune system, particularly with the context of infectious diseases and immune disorders. The study has been published in the journal Nature Aging.

Scientists have successfully tested a rapid, reliable method for assessment of heart disease risk.

The method can measure 25 important markers in the blood simultaneously, such as cholesterol, in less than 15 minutes using radio waves. This new application (currently research use only) could support more patients or people from the general population, in more locations – including regional and remote areas - to access prompt diagnosis and earlier treatment. Science is moving closer to integrating advanced molecular diagnostics into routine healthcare and preventive medicine.